Both in Pharmaceuticals
Corcept Therapeutics vs Protagonist Therapeutics
Over the past year CORT returned +8.5% and PTGX returned +83.5%; their daily moves had a correlation of 0.22.
CORT +8.5% PTGX +83.5%Growth of $1, one year, split-adjusted
| Metric | CORT | PTGX |
|---|---|---|
| Price | $80.46 | $139.37 |
| Market cap | $8.70B | $9.02B |
| Today | −0.81% | −3.78% |
| 1 month | −30.8% | −0.5% |
| 6 months | +55.9% | +40.0% |
| Year to date | +131.2% | +59.6% |
| 1 year | +11.3% | +79.0% |
| Revenue growth (YoY) | +31.7% | +3749.2% |
| Gross margin | 98.4% | 100.0% |
| Net margin | 16.8% | 76.3% |
| P/E (TTM) | 159.6× | 108.8× |
| Price / sales | 10.5× | 32.0× |
| Net cash | $308.2M | $782.6M |
| Dividend yield | — | — |
| Volatility (60d) | 59.6% | 32.2% |
| Short % of float | 9.0% | 16.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).